Atypical presentations of fungal osteomyelitis during post COVID-19 outbreak - Case series

Ankita Chugh1, Akhilesh Kumar Pandey1, Amit Goyal2

  • 1Department of Dentistry, Oral and Maxillofacial Surgery, All India Institute of Medical Sciences, Jodhpur, India.

Abstract

Insights

Fungal osteomyelitis, including mucormycosis and aspergillosis, has increased post-COVID-19, presenting atypically. Early surgical intervention and antifungal treatment are crucial for successful outcomes in these opportunistic infections.

Area of Science:

  • Mycology
  • Infectious Diseases
  • Oral and Maxillofacial Surgery

Background:

  • Opportunistic fungal infections like mucormycosis and aspergillosis pose significant health risks.
  • A global increase in fungal osteomyelitis has been observed following the COVID-19 pandemic.
  • Atypical presentations of fungal osteomyelitis require careful diagnostic consideration.

Observation:

  • This case series details three atypical fungal osteomyelitis cases: mandibular, space infection mimic, and maxillary sinus involvement.
  • Two patients presented with mandibular fungal osteomyelitis.
  • One middle-aged male exhibited fungal osteomyelitis mimicking a space infection, and another case involved suspected mixed fungal osteomyelitis in the maxillary sinus.

Findings:

  • Aggressive surgical debridement combined with antifungal therapy (Liposomal Amphotericin B, Posaconazole) was the primary treatment approach.
  • All reported cases of fungal osteomyelitis achieved successful treatment outcomes.
  • No recurrence of fungal osteomyelitis was observed post-treatment in the managed cases.

Implications:

  • COVID-19 patients, particularly those on corticosteroids, are more susceptible to opportunistic fungal osteomyelitis due to their immunocompromised state.
  • Prompt diagnosis and aggressive surgical intervention are critical for managing fungal osteomyelitis.
  • Delayed treatment of fungal osteomyelitis can significantly increase mortality rates, underscoring the need for timely and effective management strategies.

Related Concept Videos

Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
35
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
648
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
35
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
343
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
481
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
486